Growing community of inventors

San Diego, CA, United States of America

Andrea Fanjul

Average Co-Inventor Count = 6.08

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 48

Andrea FanjulCatherine Tachdjian (6 patents)Andrea FanjulLyle W Spruce (6 patents)Andrea FanjulMagnus Pfahl (6 patents)Andrea FanjulHussien A Al-Shamma (6 patents)Andrea FanjulDavid P M Pleynet (5 patents)Andrea FanjulTorsten R Wiemann (2 patents)Andrea FanjulKacey Sachen (2 patents)Andrea FanjulNikolai Suslov (2 patents)Andrea FanjulAntara Banerjee (2 patents)Andrea FanjulRobert J Hoey (2 patents)Andrea FanjulMohamed Boudjelal (1 patent)Andrea FanjulJason B Ibarra (1 patent)Andrea FanjulDavid Pm Pleynet (1 patent)Andrea FanjulAndrea Fanjul (8 patents)Catherine TachdjianCatherine Tachdjian (56 patents)Lyle W SpruceLyle W Spruce (34 patents)Magnus PfahlMagnus Pfahl (24 patents)Hussien A Al-ShammaHussien A Al-Shamma (13 patents)David P M PleynetDavid P M Pleynet (7 patents)Torsten R WiemannTorsten R Wiemann (8 patents)Kacey SachenKacey Sachen (2 patents)Nikolai SuslovNikolai Suslov (2 patents)Antara BanerjeeAntara Banerjee (2 patents)Robert J HoeyRobert J Hoey (2 patents)Mohamed BoudjelalMohamed Boudjelal (2 patents)Jason B IbarraJason B Ibarra (1 patent)David Pm PleynetDavid Pm Pleynet (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Incyte San Diego Inc. (5 from 8 patents)

2. Ortho-mcneil Pharmaceutical Corp. (3 from 363 patents)

3. Takeda Pharmaceutical Company Limited (2 from 1,177 patents)

4. Maxia Pharmaceuticals, Inc. (1 from 1 patent)


8 patents:

1. 12202901 - Cannabinoid receptor type 1 (CB1) antibodies, encoding nucleic acid molecules thereof and methods of use thereof

2. 11746155 - Cannabinoid receptor type 1 (CB1) binding proteins and uses thereof

3. 7226940 - Substituted heterocycles for the treatment of diabetes and other diseases

4. 7153875 - Heterocyclic derivatives for the treatment of cancer and other proliferative diseases

5. 7071218 - N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases

6. 6974826 - Imidazolidinedione derivatives for the treatment of diabetes and other diseases

7. 6765013 - Thiazolidinedione derivatives for the treatment of diabetes and other diseases

8. 6515003 - Heterocyclic derivatives for the treatment of diabetes and other diseases

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…